Munari Alvise J. 4
4 · MSCI Inc. · Filed Jan 28, 2026
Research Summary
AI-generated summary of this filing
MSCI CPO Alvise J. Munari Receives Performance Stock Options (6,042)
What Happened
Alvise J. Munari, Chief Product Officer of MSCI Inc. (MSCI), was granted/awarded performance stock options (PSOs) covering 6,042 shares. The Form 4 reports an acquisition-type award (derivative) on 2026-01-26 at $0.00 (no cash paid at grant); the PSOs were certified as earned by the Compensation, Talent and Culture Committee.
Key Details
- Transaction date: 2026-01-26 (Form 4 filed 2026-01-28). Transaction code: A (award/grant).
- Reported amount: 6,042 PSOs (derivative) at $0.00 reported acquisition price.
- Vesting: PSOs were granted 2023-02-02 and are scheduled to vest on 2026-02-02, subject to continued service and the previously measured performance period (Jan 1, 2023–Dec 31, 2025).
- Footnote: The performance condition was certified met on Jan 26, 2026; the 6,042 PSOs represent the number earned.
- Shares owned after transaction: not specified in the disclosed excerpt.
- Timeliness: Filing appears timely (filed within two business days).
Context
This is an award of performance-based options (derivative securities), not an open-market purchase or sale. The report documents that the performance condition was met and options were earned; the options are scheduled to vest on Feb 2, 2026 (then exercisable per plan terms). The reported $0.00 reflects the award certification, not the market value of the underlying shares.
Insider Transaction Report
- Award
Option to purchase common stock
[F1]2026-01-26+6,042→ 6,042 totalExercise: $554.52From: 2026-02-02Exp: 2033-02-02→ Common Stock (6,042 underlying)
Footnotes (1)
- [F1]Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 6,042 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.